Erlonat 150 Tablet 30 is primarily used to manage advanced nonsmall cell lung cancer (NSCLC) and pancreatic cancer. This medicine falls under the category of medications known as kinase inhibitors.
It is also used in managing locally advanced or metastatic NSCLC and pancreatic cancer. It proves particularly effective for patients whose tumours possess certain mutations in the epidermal growth factor receptor (EGFR).
You should take this medication as advised by your doctor. It's crucial to inform your doctor about any existing health conditions or ongoing medications before starting this medicine. In case you experience any side effects, let your doctor know right away. To achieve the best results, it's important to continue with the medication for the duration prescribed by your doctor.